PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40626318,Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.,2025,Kai Ji; Xishan Lu; Bo Ying,"Suzhou Abogen Biosciences Co., Ltd. Suzhou Jiangsu China.; Suzhou Abogen Biosciences Co., Ltd. Suzhou Jiangsu China.; Suzhou Abogen Biosciences Co., Ltd. Suzhou Jiangsu China.",N/A
